Minerva Neurosciences, Inc. Analyst EPS Estimates
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 0 | -$0.97 | -$0.97 | -$0.97 |
Q2 2024 | 1 | -$1.01 | -$1.01 | -$1.01 |
Q3 2024 | 0 | $0.97 | $0.97 | $0.97 |
Q1 2025 | 0 | -$0.77 | -$0.77 | -$0.77 |
Q2 2025 | 0 | -$0.64 | -$0.64 | -$0.64 |
Q3 2025 | 0 | -$0.30 | -$0.30 | -$0.30 |
Q4 2025 | 0 | -$0.32 | -$0.32 | -$0.32 |
Minerva Neurosciences, Inc. Earnings Date And Information
Minerva Neurosciences, Inc. last posted its earnings results on Tuesday, August 6th, 2024. The company reported $-1.09 earnings per share for the quarter, missing analysts' consensus estimates of $-0.97 by $0.12. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Minerva Neurosciences, Inc. has generated $-5 earnings per share over the last year ($-4.61 diluted earnings per share) and currently has a price-to-earnings ratio of -0.6. Minerva Neurosciences, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 5th, 2024 based on prior year's report dates.
Minerva Neurosciences, Inc. Earnings History by Quarter
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
08/06/2024 | Q2 2024 | -$0.97 | -$1.09 | -0.12 | $0 | $0 |
05/01/2024 | Q1 2024 | -$1.20 | -$1.13 | 0.07 | $0 | |
02/23/2024 | Q4 2023 | -$1.19 | $0 | |||
11/07/2023 | Q3 2023 | -$0.77 | -$1.03 | -0.26 | $0 | |
08/01/2023 | Q2 2023 | -$0.44 | -$1.12 | -0.68 | $0 | |
05/15/2023 | Q1 2023 | -$1.63 | -$0.67 | 0.96 | $0 | |
04/20/2023 | Q4 2022 | -$1.57 | $0 | |||
11/09/2022 | Q3 2022 | -$1.46 | -$1.61 | -0.15 | $308,550 | $0 |
08/09/2022 | Q2 2022 | -$1.84 | -$1.62 | 0.22 | $0 | |
05/04/2022 | Q1 2022 | -$1.60 | -$1.83 | -0.23 | $0 | |
03/01/2022 | Q4 2021 | -$1.60 | -$3.99 | -2.39 | $0 | |
11/08/2021 | Q3 2021 | -$1.76 | -$1.72 | 0.04 | $333,333 | $0 |
08/02/2021 | Q2 2021 | -$1.36 | -$1.98 | -0.62 | $574,000 | $0 |
05/12/2021 | Q1 2021 | $1.60 | -$1.65 | -3.25 | $0 | |
03/08/2021 | Q4 2020 | -$1.68 | -$1.40 | 0.28 | $0 | |
11/02/2020 | Q3 2020 | -$1.76 | -$1.55 | 0.21 | $0 | |
08/03/2020 | Q2 2020 | -$2.32 | $6.00 | 8.32 | $41.18 M | |
05/04/2020 | Q1 2020 | -$2.96 | -$2.48 | 0.48 | $0 | |
03/09/2020 | Q4 2019 | -$2.96 | -$6.13 | -3.17 | $0 | |
11/04/2019 | Q3 2019 | -$2.96 | -$2.86 | 0.1 | $0 |
Minerva Neurosciences, Inc. Earnings: Frequently Asked Questions
-
When is Minerva Neurosciences, Inc.'s earnings date?
Minerva Neurosciences, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 5th, 2024 based off last year's report dates.
-
How can I listen to Minerva Neurosciences, Inc.'s earnings conference call?
The conference call for Minerva Neurosciences, Inc.'s latest earnings report can be listened to online.
-
How can I read Minerva Neurosciences, Inc.'s conference call transcript?
The conference call transcript for Minerva Neurosciences, Inc.'s latest earnings report can be read online.
-
How much profit does Minerva Neurosciences, Inc. generate each year?
Minerva Neurosciences, Inc. (:NERV) has a recorded net income of $0. Minerva Neurosciences, Inc. has generated $-4.61 earnings per share over the last four quarters.
-
What is Minerva Neurosciences, Inc.'s price-to-earnings ratio?
Minerva Neurosciences, Inc. (:NERV) has a price-to-earnings ratio of -0.6 and price/earnings-to-growth ratio is -0.02.